Article Details
Retrieved on: 2024-06-12 21:04:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
Cellectis SA, a biotech company, reported a significant advance in using TALEN technology for gene therapy to correct the HBB gene in sickle cell disease. This breakthrough in biotechnology relates to genetic engineering and molecular biology tags.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here